General
Preferred name
PARALDEHYDE
Synonyms
Paral ()
FEMA NO. 4010 ()
NSC-9799 ()
Paraldehyde civ ()
Paracetaldehyde ()
2,4,6-trimethyl-s-trioxane ()
P&D ID
PD009047
CAS
123-63-7
1499-02-1
Tags
natural product
drug
Drug Status
investigational
approved
Drug indication
Sedative-Hypnotic
Insomnia
Max Phase
Phase 4
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
TOXICITY Paraldehyde overdosage can produce headache, nausea, drowsiness, unconsciousness, coma, severe hypotension, respiratory depression, pulmonary edema and hemorrhages, and right-side heart failure [A19738]. Inhalation of paraldehyde can produce sore throat, headache, dizziness, nausea, drowsiness and unconsciousness but exposure via this route is rare. Chronic use is dependence forming and withdrawal proceeds similarly to ethanol withdrawal producing hallucinations and convulsions. Toxic hepatitis and nephritis have been observed during chronic use.; ; The acute LD50 values determined for various species are as follows [A19738]:; ; Rabbit - 3.3-5 g/kg (oral); Rat - 1.5-1.65 g/kg (oral), 1.3-1.45 g/kg (i.p.); Dog - 3-4 g/kg (oral); Mouse - 2.75 (oral); Cat - 3.3 (oral)
Compound Sets
10
ChEMBL Approved Drugs
CHEMBL1410743
ChEMBL Drugs
CHEMBL1410743
DrugBank
DB09117
DrugBank Approved Drugs
DB09117
DrugCentral
2058
DrugCentral Approved Drugs
2058
DrugMAP
DMOC1BX
DrugMAP Approved Drugs
DMOC1BX
DrugMatrix
NPC Screening Collection
External IDs
28
Properties
(calculated by RDKit )
Molecular Weight
132.08
Hydrogen Bond Acceptors
3
Hydrogen Bond Donors
0
Rotatable Bonds
0
Ring Count
1
Aromatic Ring Count
0
cLogP
1.09
TPSA
27.69
Fraction CSP3
1.0
Chiral centers
0.0
Largest ring
6.0
QED
0.49
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Source data